HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horkay, F. Articles by Walker, D. R. Search for Related Content PubMed PubMed Citation Articles by Horkay, F. Articles by Walker, D. R.

The Annals of Thoracic Surgery, Vol 53, 822-826, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Response to heparinization in adults and children undergoing cardiac operations

F Horkay, P Martin, SM Rajah and DR Walker
Department of Cardiothoracic Surgery, Killingbeck Hospital, Leeds, United Kingdom.

The activated clotting time is an unreliable index of anticoagulation status during cardiopulmonary bypass procedures. However, modern instrumentation (Hemotec Hepcon HMS) now allows the monitoring of free heparin levels via automated protamine titration. In the present study, the standard procedure of anticoagulation at Killingbeck Hospital, Leeds, was investigated. Twenty-two pediatric patients and 20 adult patients undergoing open heart procedures involving cardiopulmonary bypass were given empirical doses of heparin (3 mg/kg body weight bolus), and activated clotting time was maintained at a level greater than 450 seconds using the Hemochron Timer. Heparin neutralization was performed at the termination of the bypass period using an empirical equivalent (3 mg/kg) of protamine sulfate. Mean free heparin concentration (+/- standard deviation) fell from 2.26 (+/- 0.45) mg/kg to 1.39 (+/- 0.34) mg/kg over the period 10 to 40 minutes on bypass in children. In adults, free heparin level declined from 2.56 (+/- 0.58) mg/kg to 1.81 (+/- 0.58) mg/kg over the same period. The biological half-life for heparin was 60 minutes in adults and 35 minutes in pediatric patients. Empirical protamine dosing resulted in excess protamine administration when compared with Hepcon titrated dose requirements: for children: median (range), 80 (12 to 350) versus 33 (12 to 97) mg, p less than 0.001; and for adults: 350 (200 to 500) versus 130 (61 to 237) mg, p less than 0.001. In conclusion, empirical heparin administration (3 mg/kg) does not result in "steady-state" anticoagulation during cardiopulmonary bypass, and empirical administration of protamine takes no account of interindividual differences in heparin sensitivity and biological half-life, which may be assessed using the Hepcon HMS.

This article has been cited by other articles:

				N. A. Guzzetta, T. Bajaj, T. Fazlollah, F. Szlam, E. Wilson, A. Kaiser, S. R. Tosone, and B. E. Miller A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass Anesth. Analg., February 1, 2008; 106(2): 419 - 425. [Abstract] [Full Text] [PDF]

				E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF]

				A. Vincentelli, B. Jude, and S. Belisle Antithrombotic therapy in cardiac surgery: [Traitement antithrombotique en chirurgie cardiaque]. Can J Anesth, June 1, 2006; 53(6_suppl): S89 - S102. [Abstract] [Full Text] [PDF]

				N. A. Guzzetta, B. E. Miller, K. Todd, F. Szlam, R. H. Moore, and S. R. Tosone An Evaluation of the Effects of a Standard Heparin Dose on Thrombin Inhibition During Cardiopulmonary Bypass in Neonates Anesth. Analg., May 1, 2005; 100(5): 1276 - 1282. [Abstract] [Full Text] [PDF]

				P. K. Neema, P. K. Sinha, and R. C. Rathod Activated Clotting Time During Cardiopulmonary Bypass: Is Repetition Necessary During Open Heart Surgery? Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 47 - 52. [Abstract] [Full Text] [PDF]

				P. J. Santrach Devices for Monitoring Heparin and Protamine in the Operating Room Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 379 - 385. [Abstract] [PDF]

				W. C. Oliver Jr Overview of Heparin and Protamine Management and Dosing Regimens in Pediatric Cardiac Surgical Patients Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 387 - 410. [Abstract] [PDF]

				I. Shen, C. Giacomuzzi, and R. M. Ungerleider Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants Ann. Thorac. Surg., February 1, 2003; 75(2): S729 - 734. [Abstract] [Full Text] [PDF]

				L. Shore-Lesserson Monitoring the Hematologic Complications of Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 207 - 216. [Abstract] [PDF]

				R. Hansen, A. Koster, M. Kukucka, F. Mertzlufft, and H. Kuppe A Quick Anti-Xa-Activity-Based Whole Blood Coagulation Assay for Monitoring Unfractionated Heparin During Cardiopulmonary Bypass: A Pilot Investigation Anesth. Analg., September 1, 2000; 91(3): 533 - 538. [Abstract] [Full Text] [PDF]

				M. Codispoti and P. S Mankad Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice Perfusion, May 1, 2000; 15(3): 191 - 201. [Abstract] [PDF]

				A. S. Weisinger and J. H. Levy Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 259 - 271. [Abstract] [PDF]

				S. Bannan, A. Danby, D. Cowan, S. Ashraf, and P. G. Martin Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy? Ann. Thorac. Surg., March 1, 1997; 63(3): 663 - 668. [Abstract] [Full Text]

				S. O. Turner-Gomes, E. P. Nitschmann, G. R. Norman, M. E. Andrew, and W. G. Williams Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss Ann. Thorac. Surg., February 1, 1997; 63(2): 482 - 488. [Abstract] [Full Text]

				Y. J. Gu, R. J. Huyzen, and W. van Oeveren INTRINSIC PATHWAY-DEPENDENT ACTIVATED CLOTTING TIME IS NOT RELIABLE FOR MONITORING ANTICOAGULATION DURING CARDIOPULMONARY BYPASS IN NEONATES J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 677 - 678. [Full Text]

				P. Martin, S. Bannan, and S. S. Ashraf Individualized patient heparinization and protamine reversal J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 493 - 493. [Full Text]

				A. G Hill, R. C Groom, B. F Akl, E. A Lefrak, and M. Kurusz Current paediatric perfusion practice in North America Perfusion, January 1, 1993; 8(1): 27 - 38. [PDF]